Home /
Insights /
Will Life Sciences Companies Face More Scrutiny in 2018?

Will Life Sciences Companies Face More Scrutiny in 2018?

January 9, 2018

Law360

Partners John Bentivoglio and Jennifer Bragg look at key enforcement trends for life sciences companies from 2017 and discuss what to expect in the year ahead.

Stay Connected

@SkaddenArps

September 18 Partner Mark Darley and associate Zoe Cooper Sutton look at the proactive approaches recently taken by borrowers in… twitter.com/i/web/status/1…
September 18 The Daily Journal has named Skadden Palo Alto partners Ken King and Mike Ringler to its annual list of the “Top 100… twitter.com/i/web/status/1…
September 17 Partners Karen Hoffman Lent and Kenneth Schwartz take a look at the antitrust treatment of wage-fixing agreements a… twitter.com/i/web/status/1…